Açıklama

Schematic overview of the molecular mechanisms by which antioxidant compounds exert their therapeutic effects in inflammatory bowel disease, including pathways related to oxidative stress reduction and inflammatory signaling modulation.

Figure 28

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 28: Schematic overview of the molecular mechanisms by which antioxidant compounds exert their therapeutic effects in inflammatory bowel disease, including pathways related to oxidative stress reduction and inflammatory signaling modulation.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Schematic overview of the molecular mechanisms by which antioxidant compounds exert their therapeutic effects in inflammatory bowel disease, including pathways related to oxidative stress reduction and inflammatory signaling modulation." />
  <figcaption>Figure 28. Schematic overview of the molecular mechanisms by which antioxidant compounds exert their therapeutic effects in inflammatory bowel disease, including pathways related to oxidative stress reduction and inflammatory signaling modulation.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

İlgili Kanıtlar

Curcumin için Ulcerative Colitis (UC)

Derece B · 5 çalışma

N-Acetyl Cysteine (NAC) için Inflammatory Bowel Disease (IBD) — General

Derece D · 1 çalışma